Unbound MEDLINE

NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Links

  • Aggregator Full Text

    • Authors

    Jilani A, George E, Adler AI

    Source

    The lancet oncology 13:6 2012 Jun pg 573-4

    MeSH

    Aged
    Androgen Antagonists
    Antineoplastic Agents, Hormonal
    Antineoplastic Combined Chemotherapy Protocols
    Disease-Free Survival
    Drug Resistance, Neoplasm
    Evidence-Based Medicine
    Great Britain
    Humans
    Male
    Middle Aged
    Neoplasm Invasiveness
    Neoplasm Staging
    Practice Guidelines as Topic
    Prognosis
    Prostatic Neoplasms
    Remission Induction
    Survival Analysis
    Taxoids
    Treatment Outcome

    Pub Type(s)

    News

    Language

    eng

    PubMed ID

    22833888